Intracellular concentration of Antiretrovirals)INCA STADY - INCA

AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA0 个研究点开始时间: 2008年1月3日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•HIV infected subjects aged 18 years or older
•naïve to antiretroviral therapy (any)
•creatinine clearance>50 ml/min
•platelet count >50000/mmc
•total neutrophils >750 cell/mmc
•hemoglobin >8 g/dl
•AST and ALT <2.5 x upper limit of normality
•total bilirubin < 1.5 mg/d
•Signed and dated written informed consent
•Patients should guarantee that they will not undergone pregnancy or prevent to be pregnant
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•pregnant women or women who are breastfeeding
•alcohol or drug abuse or any condition which might compromise the adherence of the patients to the treatment
•Urine Protein >300 mg/24 hours
•liver cirrhosis
•prior treatment with cytotoxic chemiotherapeutic agents and any agents which can induce kidney damage
•oAminoglycosides
•oAnfotericine B e.v.
•oPentamidine e.v.
•oVancomicine e.v.
•oGanciclovir
•oInterleukine 2

发起方

AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA